Effect of Quercetin supplementation on women with Polycystic ovary syndrome.

Not Applicable

• Conditions: Polycystic Ovary Syndrome.; Sclerocystic ovary syndrome Stein-Leventhal syndrome

• Registration Number: IRCT2016082215536N4
• Lead Sponsor: Vice Chancellor for research of Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 42

Inclusion Criteria

people with Body Mass Index between 25 to 40; age range of 20 to 40 year; According to the Rotterdam conference have at least 2 of the 3 criteria listed index as the disease is consider; criteria include irregular periods clinical or biochemical Hyperandrogenism and existence of Polycystic ovary base on ultrasound; willingness to cooperate; lack of medication Metformin; Oral contraceptive pill; Antihypertensive drug; lowering blood fat; Anti-inflammatory; Weight-loss drugs.
Exclusion criteria: suffering from endocrine and metabolic disease like Hypothyroidism and Hyperthyroidism; Cancer androgen manufacturer; Diabetes mellitus; Adrenal Hyperplasia; Cushing; Ovarian tumors; Hyperprolactinemia; Smoking; Pregnancy; Lactation; Menopause; allergic reaction to the supplement; withdrew the patient from the study cooperation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma Resistin. Timepoint: Before and after intervention. Method of measurement: Resitin ELISA Kit.